Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.
about
Adverse events associated with testosterone administrationTestosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practicesSex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy AgingThyroid hormone abnormalities and frailty in elderly patients with chronic kidney disease: a hypothesis.Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?Sarcopenia: etiology, clinical consequences, intervention, and assessment.The effect of testosterone and a nutritional supplement on hospital admissions in under-nourished, older peopleNutritional recommendations for the management of sarcopenia.Testosterone and weight loss: the evidence.A practical guide to male hypogonadism in the primary care setting.Sarcopenia with limited mobility: an international consensus.Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation.Hormone treatment and muscle anabolism during aging: androgens.Sarcopenia and neurosurgery.Validation of salivary testosterone as a screening test for male hypogonadism.Sarcopenia and Androgens: A Link between Pathology and Treatment.Long-term Safety of Testosterone and Growth Hormone Supplementation: A Retrospective Study of Metabolic, Cardiovascular, and Oncologic OutcomesEffects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies.Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape.Androgen treatment and muscle strength in elderly men: A meta-analysis.The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.Age-related changes in testosterone and the role of replacement therapy in older men.Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.Testosterone increases the muscle protein synthesis rate but does not affect very-low-density lipoprotein metabolism in obese premenopausal women.Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.Serum Ferritin Is Inversely Correlated with Testosterone in Boys and Young Male Adolescents: A Cross-Sectional Study in TaiwanBariatric surgery in hypothalamic obesity.Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and agingTreatment of Men for "Low Testosterone": A Systematic Review.Combined Effects of Eurycoma longifolia and Testosterone on Androgen-Deficient Osteoporosis in a Male Rat Model.The genetic pleiotropy of musculoskeletal aging.Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.Testosterone in older men after the Institute of Medicine Report: where do we go from here?Testosterone supplementation in the aging male: which questions have been answered?Male hypogonadism : an update on diagnosis and treatment.Frailty and the aging male.Drug insight: testosterone preparations.
P2860
Q24601802-F77C30D2-3358-4BC7-AD9A-DB6AE447439AQ28295533-7BC2BA54-2581-4678-B277-A133D9E5F78CQ28731543-EF2E620B-9BBB-4F5B-893F-E9D4236F43CDQ30451357-3121AAB4-6B87-4AD5-90B9-B0097D2A34B6Q30962192-3EAA09D3-97D9-4FC5-8333-CCF062D7D414Q33222142-2ADCDCF8-BAAD-491A-988C-9D90563BD775Q33569163-13F75FA1-7B33-4C8F-9D02-71F01339DE4EQ33706637-03C31CFB-C36A-4E74-8EB8-3DBCA7D527DBQ34056646-74528C3A-477B-4E4E-8303-AF79A586ED1FQ34125804-7B634B00-1993-4B95-989D-B3649147F630Q34134273-B336EDB7-7D60-41AE-8FA8-25B5F2FD9842Q34167760-885B9BBF-03D8-4F48-A136-F20D4B66D532Q34189767-CA077C8C-D2DD-4D78-A926-789FF6A3243EQ34207544-CA59182F-8645-4D6C-A8B9-83B2A0E6CD4BQ34242584-12181704-CF2C-4A91-BBE9-77F469A53621Q34356360-0C13DF2C-FA84-4A00-A6D5-B8CA1A5AD79EQ34574983-C5AE4CFA-5FDC-498E-966B-DDBDC5D44554Q34730659-F88358D0-A02A-4B10-94C1-29D053CA37F8Q35015351-5EA1C964-ABF4-4849-BFD6-35B463687527Q35032969-F4EE7BCB-3055-4C28-968B-6410AD380C74Q35142312-1E4DCBC4-AD54-4CB7-AB11-6185EC2F6843Q35546738-C9FBC2D3-1FE5-4D7A-BFE2-741DC5B40536Q35768803-B9D0D335-71F3-4239-A300-1F1C4F68EFD7Q35784175-76D474EF-6E59-4715-94D7-0BFD865AC5FCQ35810322-8FDB09A9-AC43-4D88-9E8C-864CA32917E7Q35849393-8898FABD-8F5E-48FE-BC34-43DE05B270A2Q35852422-621F3E3F-57F0-4B1D-9394-93EC6ED5FC10Q35863336-9B53B736-D522-4BE3-BF00-58CA5CEC8297Q35971290-26CE3551-C16D-445F-8909-1BC4DE647259Q36130944-A399DD05-38FD-418F-BED1-D0C2A34B8D1FQ36139976-7DCCAC89-F218-4B17-BAC6-51DFDEC62209Q36180324-3B639F1F-E09D-414E-94D5-11F454311108Q36193804-7EC8A290-C336-4A68-8419-EA55E37536CCQ36196710-0E814B31-E78E-452E-9F95-37188E9EB5C6Q36226980-FE7CC323-E90F-4532-99EE-3C4A8D547FD8Q36226990-A081E2BC-2AC2-4787-B52D-94A6FEF5F7D5Q36233399-89303E5F-47FF-4060-897D-14488611EEE3Q36268266-ECB74965-E230-48E7-8CBE-A422147EF139Q36359532-3E8E8AC9-F64C-4BA2-AE4F-BC4F20BA0531Q36675085-F0ECF5A8-EB12-4934-AEF5-788912209F8F
P2860
Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Oral testosterone supplementat ...... ith low-normal gonadal status.
@en
Oral testosterone supplementat ...... ith low-normal gonadal status.
@nl
type
label
Oral testosterone supplementat ...... ith low-normal gonadal status.
@en
Oral testosterone supplementat ...... ith low-normal gonadal status.
@nl
prefLabel
Oral testosterone supplementat ...... ith low-normal gonadal status.
@en
Oral testosterone supplementat ...... ith low-normal gonadal status.
@nl
P2093
P2860
P356
P1476
Oral testosterone supplementat ...... ith low-normal gonadal status.
@en
P2093
Gary A Wittert
Ian M Chapman
John E Morley
Matthew T Haren
Penelope Coates
Shylie Mackintosh
P2860
P304
P356
10.1093/GERONA/58.7.M618
P407
P577
2003-07-01T00:00:00Z